Hepatic Response of Magnesium-Restricted Wild Type Mice
Abstract
:1. Introduction
2. Results
2.1. Mg-Concentration in Sera and Livers of Mg-Restricted and HF-Diet Fed Mice
2.2. Body Parameters of Mg-Restricted and HF-Diet Fed Mice
2.3. Influence of Mg-Restriction and HF-Diet Feeding on Systemic Metabolic Parameters and Liver Markers
2.4. Determination of Hepatic Steatosis, Ballooning, and Inflammation in Mg-Deficient and HF-Diet Fed Mice
2.5. Hepatic Inflammatory Response to Mg-Restriction and HF-Diet Feeding
3. Discussion
4. Materials and Methods
4.1. Animal Model and Diets
4.2. Mg-Concentration in Sera and Livers
4.3. Biochemical Serum Parameters
4.4. Histological Features
4.5. Hepatic and Serum Inflammation Parameters
4.6. Statistical Analyses
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
NAFLD | non-alcoholic fatty liver disease |
Mg | Magnesium |
DMT2 | type 2 diabetes |
MetS | metabolic syndrome |
NASH | non-alcoholic steatohepatitis |
IR | insulin resistance |
IL-6 | interleukin 6 |
TNFα | tumor necrosis factor α |
HF | high-fat |
TG | triglycerides |
FFA | free fatty acids |
AST | aspartate aminotransferase |
ALT | alanine aminotransferase |
HE | hematoxylin/ eosin |
MCP-1 | monocyte chemoattractant protein-1 |
RT | room temperature |
ICPMS | inductively coupled plasma mass spectrometry |
References
- Wolf, F.I.; Cittadini, A. Chemistry and biochemistry of magnesium. Mol. Aspects Med. 2003, 24, 3–9. [Google Scholar] [CrossRef]
- Romani, A.M.; Scarpa, A. Regulation of cellular magnesium. Front. Biosci. 2000, 5, D720–D734. [Google Scholar] [CrossRef] [Green Version]
- Moshfegh, A.J.; Goldman, J.D.; Ahuja, J.K.; Rhodes, D.G.; Lacomb, R.P. What We Eat In America, NHANES 2005–2006, Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium. 2009. Available online: http://www.ars.usda.gov/ba/bhnrc/fsrg (accessed on 20 October 2021).
- Rude, R.K. Magnesium deficiency: A cause of heterogeneous disease in humans. J. Bone Miner. Res. 1998, 13, 749–758. [Google Scholar] [CrossRef]
- Barbagallo, M.; Dominguez, L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 2007, 458, 40–47. [Google Scholar] [CrossRef] [PubMed]
- Larsson, S.C.; Wolk, A. Magnesium intake and risk of type 2 diabetes: A meta-analysis. J. Intern. Med. 2007, 262, 208–214. [Google Scholar] [CrossRef]
- Toi, P.L.; Anothaisintawee, T.; Chaikledkaew, U.; Briones, J.R.; Reutrakul, S.; Thakkinstian, A. Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: An umbrella review. Nutrients 2020, 12, 2722. [Google Scholar] [CrossRef] [PubMed]
- Yu, L.; Zhang, J.; Wang, L.; Li, S.; Zhang, Q.; Xiao, P.; Wang, K.; Zhuang, M.; Jiang, Y. Association between serum magnesium and blood lipids: Influence of type 2 diabetes and central obesity. Br. J. Nutr. 2018, 120, 250–258. [Google Scholar] [CrossRef] [Green Version]
- Kostov, K. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: Focusing on the processes of insulin secretion and signaling. Int. J. Mol. Sci. 2019, 20, 1351. [Google Scholar] [CrossRef] [Green Version]
- Ford, E.S.; Li, C.; McGuire, L.C.; Mokdad, A.H.; Liu, S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U. S. adults. Obesity 2007, 15, 1139–1146. [Google Scholar] [CrossRef]
- Zhu, Z.; He, Y.; Wu, F.; Zhao, L.; Wu, C.; Lu, Y.; Zang, J.; Wang, Z.; Sun, J.; Huang, J.; et al. The associations of dietary iron, zinc and magnesium with metabolic syndrome in China’s mega cities. Nutrients 2020, 12, 659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sontia, B.; Touyz, R.M. Role of magnesium in hypertension. Arch. Biochem. Biophys. 2007, 458, 33–39. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Yang, H.; Mao, Y. Magnesium and liver disease. Ann Transl Med. 2019, 7, 578–586. [Google Scholar] [CrossRef]
- Simón, J.; Delgado, T.C.; Martinez-Cruz, L.A.; Martínez-Chantar, M.L. Magnesium, little known but possibly relevant: A link between NASH and related comorbidities. Biomedicines 2021, 9, 125. [Google Scholar] [CrossRef]
- Larter, C.Z.; Chitturi, S.; Heydet, D.; Farrell, G.C. A fresh look at NASH pathogenesis. Part 1: The metabolic movers. J. Gastroenterol. Hepatol. 2010, 25, 672–690. [Google Scholar]
- Neuschwander-Tetri, B.A. Nonalcoholic steatohepatitis and the metabolic syndrome. Am. J. Med. Sci. 2005, 330, 326–335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Williams, C.D.; Stengel, J.; Asike, M.I.; Torres, D.M.; Shaw, J.; Contreras, M.; Landt, C.L.; Harrison, S.A. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011, 140, 124–131. [Google Scholar] [CrossRef]
- Adams, L.A.; Lymp, J.F.; St Sauver, J.; Sanderson, S.O.; Lindor, K.D.; Feldstein, A.; Angulo, P. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005, 129, 113–121. [Google Scholar] [CrossRef] [PubMed]
- Dam-Larsen, S.; Franzmann, M.; Andersen, I.B.; Christoffersen, P.; Jensen, L.B.; Sorensen, T.I.; Becker, U.; Bendtsen, F. Long term prognosis of fatty liver: Risk of chronic liver disease and death. Gut 2004, 53, 750–755. [Google Scholar] [CrossRef] [Green Version]
- Bhala, N.; Angulo, P.; van der Poorten, D.; Lee, E.; Hui, J.M.; Saracco, G.; Adams, L.A.; Charatcharoenwitthaya, P.; Topping, J.H.; Bugianesi, E.; et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology 2011, 54, 1208–1216. [Google Scholar] [CrossRef] [Green Version]
- Sheka, A.C.; Adeyi, O.; Thompson, J.; Hameed, B.; Crawford, P.A.; Ikramuddin, S. Nonalcoholic steatohepatitis: A review. JAMA 2020, 323, 1175–1183. [Google Scholar] [CrossRef]
- Ludwig, J.; Viggiano, T.R.; McGill, D.B.; Oh, B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnaMed. disease. Mayo Clin. Proc. 1980, 55, 434–438. [Google Scholar]
- Yeh, M.M.; Brunt, E.M. Pathology of nonalcoholic fatty liver disease. Am. J. Clin. Pathol. 2007, 128, 837–847. [Google Scholar] [CrossRef] [PubMed]
- Balon, T.W.; Gu, J.L.; Tokuyama, Y.; Jasman, A.P.; Nadler, J.L. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 1995, 269, E745–E752. [Google Scholar] [CrossRef]
- Kandeel, F.R.; Balon, E.; Scott, S.; Nadler, J.L. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 1996, 45, 838–843. [Google Scholar] [CrossRef]
- Venu, L.; Padmavathi, I.J.; Kishore, Y.D.; Bhanu, N.V.; Rao, K.R.; Sainath, P.B.; Ganeshan, M.; Raghunath, M. Long-term effects of maternal magnesium restriction on adiposity and insulin resistance in rat pups. Obesity 2008, 16, 1270–1276. [Google Scholar] [CrossRef]
- Voma, C.; Etwebi, Z.; Soltani, D.A.; Croniger, C.; Romani, A. Low hepatic Mg content promotes liver dysmetabolism: Implications for the metabolic syndrome. J. Metab. Syndr. 2014, 3, 165–181. [Google Scholar] [PubMed] [Green Version]
- Barfell, A.; Crumbly, A.; Romani, A. Enhanced glucose 6-phosphatase activity in liver of rats exposed to Mg(2+)-deficient diet. Arch. Biochem. Biophys. 2011, 509, 157–163. [Google Scholar] [CrossRef] [Green Version]
- Nassir, F.; Mazur, A.; Giannoni, F.; Gueux, E.; Davidson, N.O.; Rayssiguier, Y. Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim. Biophys. Acta 1995, 1257, 125–132. [Google Scholar] [CrossRef]
- Pachikian, B.D.; Neyrinck, A.M.; Deldicque, L.; de Backer, F.C.; Catry, E.; Dewulf, E.M.; Sohet, F.M.; Bindels, L.B.; Everard, A.; Francaux, M.; et al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J. Nutr. 2010, 140, 509–514. [Google Scholar] [CrossRef] [Green Version]
- Mazur, A.; Maier, J.A.; Rock, E.; Gueux, E.; Nowacki, W.; Rayssiguier, Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch. Biochem. Biophys. 2007, 458, 48–56. [Google Scholar] [CrossRef]
- Nielsen, F.H. Magnesium, inflammation, and obesity in chronic disease. Nutr. Rev. 2010, 68, 333–340. [Google Scholar] [CrossRef]
- Rayssiguier, Y.; Mazur, A. Magnesium and inflammation: Lessons from animal models. Clin. Calcium 2005, 15, 245–248. [Google Scholar]
- Bussiere, L.; Mazur, A.; Gueux, E.; Nowacki, W.; Rayssiguier, Y. Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. Magnes. Res. 1995, 8, 151–157. [Google Scholar] [PubMed]
- Petrault, I.; Zimowska, W.; Mathieu, J.; Bayle, D.; Rock, E.; Favier, A.; Rayssiguier, Y.; Mazur, A. Changes in gene expression in rat thymocytes identified by cDNA array support the occurrence of oxidative stress in early magnesium deficiency. Biochim. Biophys. Acta 2002, 1586, 92–98. [Google Scholar] [CrossRef] [Green Version]
- Freedman, A.M.; Mak, I.T.; Stafford, R.E.; Dickens, B.F.; Cassidy, M.M.; Muesing, R.A.; Weglicki, W.B. Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am. J. Physiol. 1992, 262, C1371–C1375. [Google Scholar] [CrossRef] [PubMed]
- Mak, I.T.; Dickens, B.F.; Komarov, A.M.; Wagner, T.L.; Phillips, T.M.; Weglicki, W.B. Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol. Cell Biochem. 1997, 176, 35–39. [Google Scholar] [CrossRef] [PubMed]
- Rock, E.; Astier, C.; Lab, C.; Malpuech, C.; Nowacki, W.; Gueux, E.; Mazur, A.; Rayssiguier, Y. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 1995, 8, 237–242. [Google Scholar] [PubMed]
- Song, Y.; Ridker, P.M.; Manson, J.E.; Cook, N.R.; Buring, J.E.; Liu, S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U. S. women. Diabetes Care. 2005, 28, 1438–1444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, M.; Dudley, S.C., Jr. Magnesium, oxidative stress, inflammation, and cardiovascular disease. Antioxidants 2020, 9, 907. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Hernandez, H.; Gonzalez, J.L.; Rodriguez-Moran, M.; Guerrero-Romero, F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch. Med. Res. 2005, 36, 362–366. [Google Scholar] [CrossRef] [PubMed]
- Barrea, L.; di Somma, C.; Muscogiuri, G.; Tarantino, G.; Tenore, G.C.; Orio, F.; Colao, A.; Savastano, S. Nutrition, inflammation and liver-spleen axis. Crit. Rev. Food Sci. Nutr. 2018, 58, 3141–3158. [Google Scholar] [CrossRef] [Green Version]
- Patrick, L. Nonalcoholic fatty liver disease: Relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern. Med. Rev. 2002, 7, 276–291. [Google Scholar] [PubMed]
- Fengler, V.H.; Macheiner, T.; Kessler, S.M.; Czepukojc, B.; Gemperlein, K.; Muller, R.; Kiemer, A.K.; Magnes, C.; Haybaeck, J.; Lackner, C.; et al. Susceptibility of different mouse wild type strains to develop diet-induced NAFLD/AFLD-associated liver disease. PLoS ONE 2016, 11, e0155163. [Google Scholar] [CrossRef] [PubMed]
- Watanabe, M.; Shinohara, A.; Matsukawa, T.; Chiba, M.; Wu, J.; Iesaki, T.; Okada, T. Chronic magnesium deficiency decreases tolerance to hypoxia/reoxygenation injury in mouse heart. Life Sci. 2011, 88, 658–663. [Google Scholar] [CrossRef]
- Ito, M.; Suzuki, J.; Tsujioka, S.; Sasaki, M.; Gomori, A.; Shirakura, T.; Hirose, H.; Ito, M.; Ishihara, A.; Iwaasa, H.; et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol. Res. 2007, 37, 50–57. [Google Scholar] [CrossRef]
- Kugelmas, M.; Hill, D.B.; Vivian, B.; Marsano, L.; McClain, C.J. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003, 38, 413–419. [Google Scholar] [CrossRef] [PubMed]
- Mizuhara, H.; O’Neill, E.; Seki, N.; Ogawa, T.; Kusunoki, C.; Otsuka, K.; Satoh, S.; Niwa, M.; Senoh, H.; Fujiwara, H. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 1994, 179, 1529–1537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Akiyama, S.; Uehara, M.; Katsumata, S.; Ihara, H.; Hashizume, N.; Suzuki, K. Effects of dietary ascorbic acid supplementation on lipid peroxidation and the lipid content in the liver and serum of magnesium-deficient rats. Magnes. Res. 2008, 21, 232–236. [Google Scholar] [PubMed]
- Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology 2012, 142, 711.e6–725.e6. [Google Scholar] [CrossRef] [PubMed]
- Rayssiguier, Y.; Gueux, E.; Weiser, D. Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J. Nutr. 1981, 111, 1876–1883. [Google Scholar] [CrossRef]
- Takemoto, S.; Yamamoto, A.; Tomonaga, S.; Funaba, M.; Matsui, T. Magnesium deficiency induces the emergence of mast cells in the liver of rats. J. Nutr. Sci. Vitaminol. 2013, 59, 560–563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gyamfi, M.A.; Damjanov, I.; French, S.; Wan, Y.J. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem. Pharmacol. 2008, 75, 981–995. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Control | Mg-Restricted | Hf-Diet | |
---|---|---|---|
Steatosis | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.6 * ± 0.5 |
Lobular inflammation | 0.4 ± 0.9 | 0.8 ± 0.4 | 0.2 ± 0.4 |
Ballooning | 0.0 ± 0.0 | 0.8 * ± 0.4 | 1.8 * ± 0.4 |
Sum | 0.4 ± 0.9 | 1.6 * ± 0.5 | 2.6 * ± 0.5 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fengler, V.H.; Macheiner, T.; Goessler, W.; Ratzer, M.; Haybaeck, J.; Sargsyan, K. Hepatic Response of Magnesium-Restricted Wild Type Mice. Metabolites 2021, 11, 762. https://doi.org/10.3390/metabo11110762
Fengler VH, Macheiner T, Goessler W, Ratzer M, Haybaeck J, Sargsyan K. Hepatic Response of Magnesium-Restricted Wild Type Mice. Metabolites. 2021; 11(11):762. https://doi.org/10.3390/metabo11110762
Chicago/Turabian StyleFengler, Vera H., Tanja Macheiner, Walter Goessler, Maria Ratzer, Johannes Haybaeck, and Karine Sargsyan. 2021. "Hepatic Response of Magnesium-Restricted Wild Type Mice" Metabolites 11, no. 11: 762. https://doi.org/10.3390/metabo11110762